Operating Lease, Liability, Current of Vitro Biopharma, Inc. from 31 Oct 2022 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary: Vitro Biopharma, Inc. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Oct 2022 to 31 Oct 2025.
Vitro Biopharma, Inc. Operating Lease, Liability, Current for the quarter ending 31 Oct 2025 was $136,813, a 13% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Current, Quarterly (USD)

Operating Lease, Liability, Current, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$136,813	+$15,669	+13%	31 Oct 2025	10-K	13 Feb 2026	2025	FY
Q2 2025	$111,955	-$10,185	-8.3%	31 Jul 2025	10-Q	12 Sep 2025	2025	Q3
Q1 2025	$114,382	-$10,389	-8.3%	30 Apr 2025	10-Q	20 Jun 2025	2025	Q2
Q4 2024	$116,900	-$10,526	-8.3%	31 Jan 2025	10-Q	20 Mar 2025	2025	Q1
Q3 2024	$121,144	-$9,006	-6.9%	31 Oct 2024	10-K	13 Feb 2026	2025	FY
Q2 2024	$122,140	-$3,723	-3%	31 Jul 2024	10-Q	16 Sep 2024	2024	Q3
Q1 2024	$124,771	+$77,284	+163%	30 Apr 2024	10-Q	31 May 2024	2024	Q2
Q4 2023	$127,426	+$78,672	+161%	31 Jan 2024	10-Q	14 Mar 2024	2024	Q1
Q3 2023	$130,150	+$80,095	+160%	31 Oct 2023	10-K	28 Jan 2025	2024	FY
Q2 2023	$125,863			31 Jul 2023	10-Q	28 Aug 2023	2023	Q3
Q1 2023	$47,487			30 Apr 2023	10-Q	13 Jun 2023	2023	Q2
Q4 2022	$48,754			31 Jan 2023	10-Q	14 Mar 2023	2023	Q1
Q3 2022	$50,055			31 Oct 2022	10-K	29 Jan 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.